Kose Corp
TSE:4922
Kose Corp
Operating Income
Kose Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kose Corp
TSE:4922
|
Operating Income
¥16B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
0%
|
|
Shiseido Co Ltd
TSE:4911
|
Operating Income
¥19.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Operating Income
¥40.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Operating Income
¥16.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
0%
|
|
Kao Corp
TSE:4452
|
Operating Income
¥86.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-4%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Operating Income
¥25.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
See Also
What is Kose Corp's Operating Income?
Operating Income
16B
JPY
Based on the financial report for Dec 31, 2023, Kose Corp's Operating Income amounts to 16B JPY.
What is Kose Corp's Operating Income growth rate?
Operating Income CAGR 10Y
0%
Over the last year, the Operating Income growth was -28%. The average annual Operating Income growth rates for Kose Corp have been 6% over the past three years , -22% over the past five years .